Your browser doesn't support javascript.
loading
Hodgkinoid histiocytosis: an atypical nodal CD30 and S100-positive histiocytosis with eosinophilia.
Tsuyama, Naoko; Noguchi, Masaaki; Asaka, Reimi; Sakata, Seiji; Baba, Satoko; Izumi, Hiroshi; Takeuchi, Kengo.
Afiliación
  • Tsuyama N; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Noguchi M; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Asaka R; Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan.
  • Sakata S; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Baba S; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Izumi H; Pathology project for molecular targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Histopathology ; 81(3): 371-379, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35789115
ABSTRACT
Histiocytes and dendritic cells may display cytological atypia and an aberrant immunophenotype even in reactive processes. Herein, we describe two cases of "Hodgkinoid histiocytosis" that show distinctive clinicopathological features, mimicking morphologically classic Hodgkin lymphoma (CHL), but suggesting reactive histiocytic/dendritic cell proliferation in lymph nodes. Both the patients presented with peripheral lymphadenopathy and blood eosinophilia with skin manifestations. Lymph node biopsy revealed scattered large histiocytes resembling Hodgkin cells with a round or stellate shape, abundant cytoplasm, and distinct nucleoli admixed in a predominant inflammatory background. The Hodgkinoid histiocytes occasionally showed emperipolesis. They expressed CD30, S100, and PD-L1 proteins but lacked PAX5 and CD1a expressions, Epstein-Barr association, BRAF V600E mutation, and PD-L1 gene amplification. Neither of the patients showed overt progression to malignant haematopoietic neoplasms during the disease course. An identical case series of four patients has been reported to date. Both these series highlight the potential of being interpreted as CHL due to the presence of Hodgkinoid histiocytes with CD30 positivity.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Histiocitosis / Eosinofilia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Histopathology Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Histiocitosis / Eosinofilia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Histopathology Año: 2022 Tipo del documento: Article País de afiliación: Japón